Return to Statistics Toolbox

Pathway mapping for Study ST003261

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:Breast cancer cells | Treatment:10 µM Comp. 1 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:10 µM Comp. 2 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:10 µM Comp. 3 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:24 h (3)
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:4 h (3)
Sample source:Breast cancer cells | Treatment:10 µM RSL3 | time point:6 h (3)
Sample source:Breast cancer cells | Treatment:1 µM Comp. 1 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:1 µM Comp. 2 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:1 µM Comp. 3 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:1 µM RSL3 + 3 µM Ferrostatin | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:24 h (3)
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:2 h (6)
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:4 h (3)
Sample source:Breast cancer cells | Treatment:1 µM RSL3 | time point:6 h (3)
Sample source:Breast cancer cells | Treatment:3 µM Comp. 1 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:3 µM Comp. 2 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:3 µM Comp. 3 | time point:2 h (3)
Sample source:Breast cancer cells | Treatment:DMSO | time point:24 h (3)
Sample source:Breast cancer cells | Treatment:DMSO | time point:2 h (6)
Sample source:Breast cancer cells | Treatment:DMSO | time point:4 h (3)
Sample source:Breast cancer cells | Treatment:DMSO | time point:6 h (3)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo